If you liked this article you might like

Biomarin Rare Disease Drug Picks Up European Endorsement Ahead of FDA Action
I'm Big on Housing Entering Quarter No. 2
Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears
Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference